BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 25624441)

  • 1. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
    Yang JJ; Landier W; Yang W; Liu C; Hageman L; Cheng C; Pei D; Chen Y; Crews KR; Kornegay N; Wong FL; Evans WE; Pui CH; Bhatia S; Relling MV
    J Clin Oncol; 2015 Apr; 33(11):1235-42. PubMed ID: 25624441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
    Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
    BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia.
    Liang DC; Yang CP; Liu HC; Jaing TH; Chen SH; Hung IJ; Yeh TC; Lin TH; Lai CL; Lai CY; Shih LY
    Pharmacogenomics J; 2016 Nov; 16(6):536-539. PubMed ID: 26503813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
    Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
    Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C
    Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia.
    Tanaka Y; Kato M; Hasegawa D; Urayama KY; Nakadate H; Kondoh K; Nakamura K; Koh K; Komiyama T; Manabe A
    Br J Haematol; 2015 Oct; 171(1):109-15. PubMed ID: 26033531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia].
    Tanaka Y
    Rinsho Ketsueki; 2017; 58(8):950-956. PubMed ID: 28883280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia].
    Hao QS; Wang Z; Fang QY; Gong XY; Liu KQ; Li Y; Wei H; Wang Y; Li QH; Wang M; Tian Z; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):911-916. PubMed ID: 35045652
    [No Abstract]   [Full Text] [Related]  

  • 9. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
    Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
    J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants.
    Wang DS; Yu CH; Lin CY; Chang YH; Lin KH; Lin DT; Jou ST; Lu MY; Chang HH; Lin SW; Chen HY; Yang YL
    Pediatr Res; 2021 Jan; 89(1):217-222. PubMed ID: 32221476
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Fan POL; Leung KT; Chan KYY; Leung AWK; Lam GKS; Chow TTW; Cheng FWT; Yuen LYP; Moriyama T; Yang JJ; Li CK
    Pediatr Hematol Oncol; 2022 Apr; 39(3):254-266. PubMed ID: 34665987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of
    Nghia H; Than HH; Dong CV; Oanh TTK; Truc VTT; Ngan CTT; Ngon HT; Binh NT; Dung PC; Anh Vu H; Xinh PT
    Pediatr Hematol Oncol; 2022 Sep; 39(6):561-570. PubMed ID: 35156873
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Puangpetch A; Tiyasirichokchai R; Pakakasama S; Wiwattanakul S; Anurathapan U; Hongeng S; Sukasem C
    Pharmacogenomics; 2020 Apr; 21(6):403-410. PubMed ID: 32308129
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia.
    Buaboonnam J; Sripatanatadasakul P; Treesucon A; Glomglao W; Siraprapapat P; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Sinlapamongkolkul P; Sanpakit K
    Pediatr Int; 2019 Aug; 61(8):754-758. PubMed ID: 31166660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel variants in
    Moriyama T; Yang YL; Nishii R; Ariffin H; Liu C; Lin TN; Yang W; Lin DT; Yu CH; Kham S; Pui CH; Evans WE; Jeha S; Relling MV; Yeoh AE; Yang JJ
    Blood; 2017 Sep; 130(10):1209-1212. PubMed ID: 28659275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prominence of NUDT15 genetic variation associated with 6-mercaptopurine tolerance in a genome-wide association study of Japanese children with acute lymphoblastic leukaemia.
    Tanaka Y; Urayama KY; Mori M; Arakawa Y; Hasegawa D; Noguchi Y; Yanagimachi M; Keino D; Ota S; Akahane K; Inukai T; Hangai M; Kawaguchi T; Takagi M; Koh K; Matsuda F; Manabe A
    Br J Haematol; 2022 Oct; 199(2):260-269. PubMed ID: 35961941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mercaptopurine induced myelosuppression in a child with a
    Gupta N; Magatha LS; Jayaraman D; Scott JX; Antony SB; Koshy T
    J Oncol Pharm Pract; 2023 Jun; 29(4):999-1001. PubMed ID: 36341754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia.
    Tanaka Y; Nakadate H; Kondoh K; Nakamura K; Koh K; Manabe A
    Pharmacogenomics J; 2018 Apr; 18(2):275-280. PubMed ID: 28418010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age.
    Suzuki H; Fukushima H; Suzuki R; Hosaka S; Yamaki Y; Kobayashi C; Sakai A; Imagawa K; Iwabuchi A; Yoshimi A; Nakao T; Kato K; Tsuchida M; Kiyokawa N; Koike K; Noguchi E; Fukushima T; Sumazaki R
    J Hum Genet; 2016 Sep; 61(9):797-801. PubMed ID: 27193222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of
    Du S; Huang X; He X; Mao M; Chen M; Zhang R; Shao H; Lv Z; Liu X; Chuan J
    Haematologica; 2024 Apr; 109(4):1053-1068. PubMed ID: 37794799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.